Fischer Medical Ventures Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.- Revised
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fischer Medical Ventures Limited reported a standalone revenue of Rs. 1,739.18 lakhs for FY26, a 233% increase from Rs. 521.97 lakhs in FY25. However, the company swung to a standalone net loss of Rs. 1,042.29 lakhs compared to a profit of Rs. 66.32 lakhs in FY25. Consolidated revenue declined to Rs. 9,773.04 lakhs from Rs. 11,069.87 lakhs, with consolidated net loss of Rs. 711.94 lakhs vs profit of Rs. 1,923.48 lakhs. Finance costs surged significantly to Rs. 583.40 lakhs (consolidated) from Rs. 46.68 lakhs, indicating heavy debt servicing. Operating cash flow remained negative at Rs. 290.62 lakhs. The company declared a dividend of Rs. 0.05 per share. Auditors issued an unmodified (clean) opinion. The company also appointed S. Ramanand Aiyer & Co. as internal auditors for FY27 and completed incorporation of FMV Global Innovation Pte Ltd.
The company showed strong standalone revenue growth but shifted to significant losses due to high finance costs and expenses. Negative operating cash flow and increased borrowings raise concerns about financial health despite clean audit opinion.